Litcius/Paper detail

Crataegus laevigata Suppresses LPS-Induced Oxidative Stress during Inflammatory Response in Human Keratinocytes by Regulating the MAPKs/AP-1, NFκB, and NFAT Signaling Pathways

Quynh T. N. Nguyen, Minzhe Fang, Mengyang Zhang, Nhung Quynh, Min‐Seon Kim, Sheng Zheng, Eunson Hwang, Tae‐Hoo Yi

2021Molecules13 citationsDOIOpen Access PDF

Abstract

Crataegus laevigata belongs to the family Rosaceae, which has been widely investigated for pharmacological effects on the circulatory and digestive systems. However, there is limited understanding about its anti-oxidative stress and anti-inflammatory effects on skin. In this study, 70% ethanol C. laevigata berry extract (CLE) was investigated on lipopolysaccharide (LPS)-stimulated keratinocytes. The LPS-induced overproduction of reactive oxygen species (ROS) was suppressed by the treatment with CLE. In response to ROS induction, the overexpression of inflammatory regulating signaling molecules including mitogen-activated protein kinases (MAPK)/activator protein-1 (AP-1), nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB), and nuclear factor of activated T-cells (NFAT) were reduced in CLE-treated human keratinocytes. Consequently, CLE significantly suppressed the mRNA levels of pro-inflammatory chemokines and interleukins in LPS-stimulated cells. Our results indicated that CLE has protective effects against LPS-induced injury in an in vitro model and is a potential alternative agent for inflammatory treatment.

Topics & Concepts

NFATOxidative stressMAPK/ERK pathwayLipopolysaccharideCell biologyNF-κBNFKB1ChemistryReactive oxygen speciesp38 mitogen-activated protein kinasesChemokineSignal transductionActivator (genetics)PharmacologyBiologyInflammationImmunologyBiochemistryTranscription factorReceptorGeneBotanical Studies and ApplicationsFungal Biology and ApplicationsPhytochemicals and Antioxidant Activities
Crataegus laevigata Suppresses LPS-Induced Oxidative Stress during Inflammatory Response in Human Keratinocytes by Regulating the MAPKs/AP-1, NFκB, and NFAT Signaling Pathways | Litcius